Singapore-based global investment firm Temasek has joined the $70-million Series B funding round for US agriculture startup Pivot Bio. The round was led by billionaires-backed Breakthrough Energy Ventures.
Following the capital infusion, the startup will launch Pivot Bio PROVEN, which it claims are the first and only nitrogen-producing microbes in the US. The new funding will also support expanded research and development for the company’s second-generation product, a seed treatment option, as well as overseas expansion.
